Column Group IV-A, LP is 10% Owner at RAPT Therapeutics, Inc. (RAPT). They have made 4 open-market trades across 2 companies since 2022, most recently 2023-01-10.
CIK 0001796353
4 open-market purchases totalling $28.2M since 2022, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.